Average Co-Inventor Count = 8.57
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Infinity Pharmaceuticals, Inc. (6 from 108 patents)
2. Infinity Discovery, Inc. (4 from 12 patents)
3. Biogen Ma Inc. (3 from 250 patents)
4. Eisai R&d Management Co., Ltd. (1 from 527 patents)
14 patents:
1. 12391697 - Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase
2. 12240838 - Inhibiting agents for Bruton's tyrosine kinase
3. 11926619 - Certain pladienolide compounds and methods of use
4. 10899753 - Inhibiting agents for Bruton's tyrosine kinase
5. 9346769 - Tetrazolones as inhibitors of fatty acid synthase
6. 8609706 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
7. 8546432 - Tetrazolones as inhibitors of fatty acid synthase
8. 8450350 - Triazoles as inhibitors of fatty acid synthase
9. 8236956 - Cyclopamine analogues and methods of use thereof
10. 8178690 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
11. 7928244 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
12. 7875628 - Cyclopamine analogues and methods of use thereof
13. 7407967 - Cyclopamine analogues and methods of use thereof
14. 7230004 - Cyclopamine analogues and methods of use thereof